Edoxaban Tosylate Monohydrate is the tosylate salt form of Edoxaban, a potent, selective Factor Xa inhibitor used as an oral anticoagulant. Edoxaban is widely prescribed for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation, as well as for the treatment and prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE). With its predictable pharmacokinetics and once-daily dosing, Edoxaban offers a convenient alternative to traditional anticoagulants. Edoxaban Tosylate Monohydrate plays a crucial role in the formulation of Edoxaban-based therapies, contributing to its growing use in the NOAC (novel oral anticoagulant) market. Manufacturers and formulators value Edoxaban for its safety profile, efficacy, and minimal need for routine monitoring.

Explore Royal Pharma as your potential partner for Edoxaban API.